Skip to Main Content

Handling injectable cytotoxic medicines in clinical areas

Source NHSPQA CommitteePublished Last updated See all updates

Handling of injectable cytotoxic medicines in clinical areas should take into account risks to staff

Guidance

The NHS Pharmaceutical Quality Assurance Committee produced guidance and further recommendations in 2019, specific to traditional small molecule chemotherapy medicines.

For safe handling of monoclonal antibodies, refer to our series of articles Safe handling of monoclonal antibodies.

Attachments

Update history

  1. Improved accessibility. Formatting and minor amendments pending full review.
  1. Published